Category: Sickle Cell News for December 2020

Researchers tackle sickle cell disease with CRISPR-based gene editing

$1 million grant will advance personalized medicine using gene editing at ChristianaCare’s Gene Editing Institute Scientists at ChristianaCare’s Gene Editing Institute have received a $1 million grant from the Lisa Dean Moseley Foundation to develop a novel gene therapy for inherited blood disorders including sickle cell disease, offering hope to nearly 100,000 Americans suffering from …

The role of hematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing

Abstract Sickle cell disease is one of the most common, life-threatening, non-communicable diseases in the world and a major public health problem. Following the implementation of simple preventive and therapeutic modalities, infant mortality has almost been abolished in high-income countries, but only a small amount of progress has been made in improving survival in adulthood. …

Life is a Painting by Hertz Nazaire

Sharing with someone what the experience of sickle cell crisis feels like is difficult. What is that moment when pain is at its peak? How do you explain how much impact pain truly has on your life? You would think that being sick so often, it would be an easier task for me to know …